Cannabis
Medical Cannabis Innovator Khiron Continues to Disrupt Global Marketplace Signing Partnership with Teleton in Mexico
Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), the global medical cannabis leader expanding throughout Latin America and Europe, has partnered with health care company Teleton to bring access to medical cannabis to more than 24 medical centers across Mexico.
Khiron is a leader in the marketplace with its end-to-end solution focusing on the category of medical cannabis. Khiron has a proprietary, sustainable model of growing, distributing, and prescribing cannabis for a range of health care solutions in its Zerenia ™ medical cannabis clinics. Leveraging their wholly-owned medical clinics and proprietary telemedicine platforms, Khiron combines a patient-oriented approach, physician education programs, scientific expertise, product innovation, and to drive prescriptions and brand loyalty with patients worldwide.
“The establishment of Khiron’s Zerenia™ medical cannabis clinics in Teleton’s medical centers is only the beginning of our go-to-market strategy and medical partnerships in Mexico,” says Alvaro Torres, Khiron CEO and Director. “We are focused on delivering the highest quality and best care to patients and ongoing education to doctors and communities at large.”
Khiron has also obtained regulatory quotas (authorization to use a control substance under International Conventions) from Mexico’s regulatory agency COFEPRIS for importing CBD and THC into the country and is currently securing permits for imports to begin commercial sales in the country. With Mexico’s population of nearly 130 million, it is among the top 15 economies worldwide, Khiron’s serves more than 11.7 million people who have conditions treatable with medical cannabis.
Arturo Pichardo, Corporate Medical Director of Teleton, adds, “Teleton and Khiron’s Zerenia™ clinic network complement each other perfectly with our strong patient focus, as we share the same values about our common mission. This partnership is good news for patients with various medical conditions throughout Mexico.”
Khiron has also partnered with Mexico’s top university Tecnologico de Monterrey to provide medical cannabis training to doctors across the country, based on Khiron’s education programs and real-world evidence from its Zerenia™ clinics across Latin America.
Cannabis
North America Legal Cannabis Industry Report 2024: Market to Grow at a CAGR of 26.65% During 2023-2032, Bank Loans Boosting Business Growth
Cannabis
Global Legal Marijuana Strategic Business Report 2024: A $125+ Billion Market by 2030 Featuring Aphria, Aurora Cannabis, Beacon Medical, Canopy Growth, Cronos, OrganiGram, Tikun Olam, Tilray, Wayland
Cannabis
Avicanna Announces Results of Study in Patients with Epidermolysis Bullosa
-
Cannabis2 weeks ago
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
-
Humboldt2 weeks ago
Humboldt Seed Company partners with Apollo Green to bring California cannabis genetics to the global marketplace
-
Cannabis2 weeks ago
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical
-
Cannabis2 weeks ago
Sannabis, Inc. (OTC: USPS) Announces First Shipment of Cannabis Essential Oil from Colombia to U.S. to Fill First Order, as the DEA Re-Classifies Marijuana from Schedule I to Schedule III
-
Cannabis7 days ago
IM Cannabis Reports First Quarter Financial Results
-
Cannabis6 days ago
Mikra Announces Partnership with Virun NutraBiosciences Inc. and Releases CELLF 2.0
-
Innocan5 days ago
Innocan Pharma Reports Breakthrough in a Pre-Clinical Trial: Liposomal-CBD Injection Restores Mobility to an Amputee Female Donkey
-
Cannabis2 days ago
Avicanna Announces Results of Study in Patients with Epidermolysis Bullosa